Nausea, diarrhea, constipation, and reduced appetite dose-dependent and concentrated early and just after dose increases
That discovery piqued the interest of many who were researching anti-aging products aimed at addressing issues like wrinkles, reduced elasticity, and dull skin
[1] It is administered as a once-weekly subcutaneous injection starting at 2.5 mg with gradual 4-week titration increments
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper): A naturally occurring tripeptide copper complex that supports extracellular matrix remodeling, collagen and glycosaminoglycan synthesis, antioxidant activity, and modulation of inflammatory signaling in experimental systems
only one report of mild scalp itching in the active group across the entire 6-month trial Combined delivery approach: First study to test copper tripeptide serum delivered via nano-fractional radiofrequency for male pattern hair loss Pilot-scale evidence: This was a small proof-of-concept study (6 patients) the results are promising but need confirmation in larger trials All patients completed treatment: 100% retention across both groups over 6 months, suggesting excellent tolerability Evidence Summary About This Study Medical Disclaimer: This article summarises published clinical research for educational purposes only
